The UWCCC Cancer Prevention and Outcomes Data (C-POD) shared resource (formerly the Survey Research Shared Resource) provides seamless, effective, state-of-the-art project development, data collection, and data dissemination services to maximize the impact of cancer population health and clinical research at the UWCCC. Dr. Trentham-Dietz (CPC) serves as the Faculty Leader of C-POD and has > 15 years of experience in conducting epidemiologic studies, collecting survey data, and supporting multidisciplinary population health studies. Dr. Zhang serves as the Facility Manager and is experienced in survey research and utilization of national surveillance data. The remaining staff of C-POD are highly-qualified to support UWCCC members, providing services for project planning, data and sample collection, data management, and resource sharing. Three major specific aims of C-POD are as follows: 1) Project Development. Provide consultation and technical assistance to UWCCC members for designing cancer-related research studies involving surveys, personal interviews, and focus groups. 2) Data Collection. Collect quantitative and qualitative data and biological specimens using personal and telephone interviews; mailed questionnaires and internet surveys; and focus groups. 3) Data Dissemination. Acquire, store, and share data from the UWCCC cancer registry, the Wisconsin cancer registry, publicly-available data including national surveillance data, local epidemiologic and health services research studies; and connect UWCCC members with other cancer-related data resources on the UW campus, such as the Health Innovation Program and Population Health Institute. C-POD accelerates access to cancer-related data on both cancer and non-cancer (at risk) populations and works closely with other campus resources to facilitate coordinated and quality service. Concurrent with the name change to C-POD, Data Dissemination services were added in 2016 to take advantage of existing cancer-related data after completing strategic planning and assessing current and anticipated research needs of UWCCC members particularly for cancer care delivery research. Implementation of the strategic plan is supported by UWCCC supplemental investment and has facilitated an expansion of services and dramatic increase in utilization by Disease Oriented Teams (DOTs). C-POD now provides timely cancer patient, tumor, and treatment data to researchers using a novel data visualization dashboard for study planning and trial recruitment, and surveillance and cancer care delivery research. The expertise of C-POD?s staff and their experience with using numerous large data sources make the team uniquely positioned to collect, organize, and disseminate cancer-related data with UWCCC researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA014520-44S3
Application #
9772008
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Shafik, Hasnaa
Project Start
Project End
Budget Start
2018-05-30
Budget End
2019-03-31
Support Year
44
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Pleiman, Jennifer K; Irving, Amy A; Wang, Zhishi et al. (2018) The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer. PLoS Genet 14:e1007611
Kletzien, Heidi; Macdonald, Cameron L; Orne, Jason et al. (2018) Comparison Between Patient-Perceived Voice Changes and Quantitative Voice Measures in the First Postoperative Year After Thyroidectomy: A Secondary Analysis of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg 144:995-1003
Kang, Lei; Jiang, Dawei; Ehlerding, Emily B et al. (2018) Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models. Mol Pharm 15:1627-1634
Bulu, Hakan; Sippo, Dorothy A; Lee, Janie M et al. (2018) Proposing New RadLex Terms by Analyzing Free-Text Mammography Reports. J Digit Imaging 31:596-603
Jewett, Patricia I; Gangnon, Ronald E; Elkin, Elena et al. (2018) Geographic access to mammography facilities and frequency of mammography screening. Ann Epidemiol 28:65-71.e2
Albertini, Mark R (2018) The age of enlightenment in melanoma immunotherapy. J Immunother Cancer 6:80
Shull, James D; Dennison, Kirsten L; Chack, Aaron C et al. (2018) Rat models of 17?-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention. Physiol Genomics 50:215-234
Kang, Lei; Jiang, Dawei; England, Christopher G et al. (2018) ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab. Eur J Nucl Med Mol Imaging 45:1372-1381
Melgar-Asensio, Ignacio; Kandela, Irawati; Aird, Fraser et al. (2018) Extended Intravitreal Rabbit Eye Residence of Nanoparticles Conjugated With Cationic Arginine Peptides for Intraocular Drug Delivery: In Vivo Imaging. Invest Ophthalmol Vis Sci 59:4071-4081
Jang, Samuel; Rosenberg, Stephen A; Hullet, Craig et al. (2018) Value of Elective Radiation Oncology Rotations: How Many Is Too Many? Int J Radiat Oncol Biol Phys 100:558-559

Showing the most recent 10 out of 1528 publications